1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D82-018-544, DFCI-80051, DFCI-CML
|
|
2.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSTI571H2201, NCT00290771
|
|
3.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSTI571H2202, NCT00292149
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: GER-CML-3, EU-95042, NCT00002771
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI
Protocol IDs: MRC-LEUK-CML-2000, ECOG-E7995, MRC-LEUK-CML-IV, MRC-LEUK-CML-IVa, EU-96029, NCT00002868, E7995
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: adult
Sponsor:
Protocol IDs: MRC-LEUK-CML-V, EU-96028, NCT00002869
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: CMLNSG-99, NCI-V97-1349
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: CLB-19807, SWOG-C19807, NCT00004933, C19807
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Other
Protocol IDs: LRF-AML14, EU-20016, NCT00005823, ISRCTN62207270
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 18
Sponsor: NCI
Protocol IDs: POG-7615, MDAR-18, MDAR-190
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor:
Protocol IDs: BTSG-8001
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: III-MK-CML-3A, EU-20118, NCT00025402
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-357
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7216
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7424/25
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7521
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7522, MDAR-25
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7727/28
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7835
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 18
Sponsor:
Protocol IDs: WCG-123
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: WCG-123R
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor:
Protocol IDs: WCG-813
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2281
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI
Protocol IDs: EST-2483
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: NCOG-6G61
|
